Table 2.
Features of different outcomes of patients with myxoma with brain embolism.
| Characteristic | MRS 0–2 (n = 6) | MRS 3–6 (n = 9) | P |
|---|---|---|---|
| Female/male | 0/6 | 8/1 | 0.001 |
| Age, y (mean ± SD) | 55.44 ± 14.20 | 57.83 ± 10.54 | 0.748 |
| Infection, n (%) | 1 (16.7%) | 8 (88.9%) | 0.011 |
| Other severe complications*, n (%) | 1 (16.7%) | 8 (88.9%) | 0.011 |
| Hemorrhagic transformation, n (%) | 1 (16.7%) | 5 (55.6%) | 0.287 |
| Accompanying disease, n (%) | 3 (50%) | 7 (77.8%) | 0.329 |
| Systolic blood pressure, mm Hg (mean ± SD) | 135 ± 9.61 | 116.89 ± 13.71 | 0.032 |
| Diastolic blood pressure, mm Hg (mean ± SD) | 86.2 ± 11.07 | 71.89 ± 12.53 | 0.058 |
| Conscious disturbance, n (%) | 0 | 6 (66.7%) | 0.028 |
| MRI | |||
| Bilateral lesions, n (%) | 1 (16.7%) | 7 (77.8%) | 0.041 |
| Lesions count (mean ± SD) | 2.17 ± 1.21 | 4 ± 1.33 | 0.026 |
| Total anterior circulation, n (%) | 0 | 6 (66.7%) | 0.028 |
| Posterior circulation, n (%) | 1 (16.7%) | 5 (55.6%) | 0.287 |
| WBC, ×109/L (mean ± SD) | 8.21 ± 3.18 | 13.52 ± 3.52 | 0.029 |
| Hemoglobin, g/L | 139.4 ± 20.27 | 117.4 ± 14.89 | 0.053 |
| MCH pq (mean ± SD) | 29.96 ± 2.31 | 26.29 ± 3.21 | 0.059 |
| MCHC, g/L (mean ± SD) | 339.2 ± 6.62 | 320.3 ± 13.35 | 0.022 |
| IgM (mean ± SD) | 0.61 ± 0.18 | 1.22 ± 0.38 | 0.023 |
| Echocardiography | |||
| ROVT, cm (mean ± SD) | 2.97 ± 0.23 | 2.60 ± 0.25 | 0.010 |
| AO, cm (mean ± SD) | 3.24 ± 0.03 | 2.78 ± 0.22 | 0.026 |
| Myxomas length cm (mean ± SD) | 2.89 ± 1.39 | 4.6 ± 0.87 | 0.009 |
| Myxomas (length + width) cm (mean ± SD) |
4.93 ± 2.27 | 8.0 ± 2.18 | 0.017 |